Barrett's Esophagus and Barrett's-Related Dysplasia
暂无分享,去创建一个
[1] R. Lebovitz,et al. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. , 1993, Gastroenterology.
[2] S. Medendorp,et al. Superficial esophageal carcinoma. , 1995, The Annals of thoracic surgery.
[3] Edward L. Lee,et al. In situ hybridization for the detection of telomerase RNA in the progression from barrett's esophagus to esophageal adenocarcinoma , 1998, Cancer.
[4] Prateek Sharma,et al. Long-term follow-up of Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.
[5] D. Kerr,et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. , 1999, The American journal of pathology.
[6] J. Peters,et al. Definition of histopathologic changes in gastroesophageal reflux disease. , 2000, The American journal of surgical pathology.
[7] A. Younes,et al. Overexpression of Fas ligand (FasL) during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus. , 1999, Human pathology.
[8] P. Blount,et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.
[9] S. Groshen,et al. Carditis: A Manifestation of Gastroesophageal Reflux Disease , 2001, The American journal of surgical pathology.
[10] A. Sonnenberg,et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.
[11] B. Reid,et al. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. , 1987, Gastroenterology.
[12] L. Johnson,et al. Barrett's esophagus: a review. , 1983, The American journal of medicine.
[13] R. Riddell. Dysplasia in inflammatory bowel disease. , 1980, Clinics in gastroenterology.
[14] Brian J. Reid,et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort , 1992 .
[15] Stephen S. Sternberg,et al. Histology for Pathologists , 1992, Annals of Internal Medicine.
[16] R. Sampliner,et al. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.
[17] J. Peters,et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. , 1997, Annals of surgery.
[18] G. Chejfec,et al. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus , 2005, Digestive Diseases and Sciences.
[19] R. Lee. Dysplasia in Barrett's esophagus: A clinicopathologic study of six patients , 1985, The American journal of surgical pathology.
[20] J. Goldblum,et al. The gastric cardia: fact or fiction? , 2000, American Journal of Gastroenterology.
[21] R. Haggitt. Adenocarcinoma in Barrett's esophagus: a new epidemic? , 1992, Human pathology.
[22] P. Blount,et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. , 2000 .
[23] M. Bains,et al. Adenocarcinoma in Barrett's esophagus. , 1983, The Journal of thoracic and cardiovascular surgery.
[24] Patricia L. Blount,et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .
[25] Blot Wj,et al. Esophageal cancer trends and risk factors. , 1994 .
[26] J. G. van den Tweel,et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.
[27] A. Ippoliti,et al. The diagnosis of Barrett's esophagus: goblets, goblets, goblets. , 1996, Gastrointestinal endoscopy.
[28] R. Haggitt,et al. Barrett's esophagus, dysplasia, and adenocarcinoma. , 1994, Human pathology.
[29] D. Dillard,et al. Muscular anatomy of the gastroesophageal junction and role of phrenoesophageal ligament; autopsy study of sphincter mechanism. , 1966, Annals of surgery.
[30] G Van Belle,et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.
[31] F. Offner,et al. Metaplastic columnar cells in Barrett's esophagus: a common and neglected cell type. , 1996, Human pathology.
[32] S. Spechler,et al. Barrett's esophagus. , 1994, Seminars in oncology.
[33] P. Chandrasoma,et al. Histology of the gastroesophageal junction: an autopsy study. , 2000, The American journal of surgical pathology.
[34] J. Goldblum,et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. , 1999, Gastrointestinal endoscopy.
[35] W. Hop,et al. Risk factors for the development of an adenocarcinoma in columnar‐lined (Barrett) esophagus , 1993, Cancer.
[36] R. Sampliner,et al. Short segment Barrett's esophagus—the need for standardization of the definition and of endoscopic criteria , 1998, American Journal of Gastroenterology.
[37] T. Rice,et al. Surgical management of high-grade dysplasia in Barrett's esophagus. , 1993, The American journal of gastroenterology.
[38] J K Greenson,et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.
[39] F. Ellis,et al. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. , 1978, American journal of clinical pathology.
[40] G. Thomas,et al. TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. , 1994, Gastroenterology.
[41] Carissa A. Sanchez,et al. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. , 1993, Gastroenterology.
[42] M. Koike,et al. Histopathologic characteristics of early stage esophageal carcinoma: A comparative study with gastric carcinoma , 2010, Cancer.
[43] D. Skinner,et al. Dysplasia in Barrett's esophagus , 2004, Journal of Cancer Research and Clinical Oncology.
[44] J. Roth,et al. p53 gene mutations in Barrett's epithelium and esophageal cancer. , 1991, Cancer research.
[45] R. Cherian,et al. Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. , 1996, The American journal of gastroenterology.
[46] W H Henricks,et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma , 2002, Gut.
[47] R. Sampliner,et al. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. , 1989, Gastroenterology.
[48] J. Boitnott,et al. The spectrum of carcinoma arising in Barrett's esophagus: A clinicopathologic study of 26 patients , 1984, The American journal of surgical pathology.
[49] R. Wong,et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. , 1999, Gastroenterology.
[50] R. Goyal,et al. The histologic spectrum of Barrett's esophagus. , 1976, The New England journal of medicine.
[51] R. R. Smith,et al. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. , 1987, American journal of clinical pathology.
[52] B. Reid,et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. , 1988, Gastroenterology.
[53] R. Goyal,et al. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. , 1996, Gastroenterology.
[54] M. Sivak,et al. Barrett's esophagus. A review of the pathologist's role in diagnosis and management. , 1991, Pathology annual.
[55] Tarun Mullick. Telomerase upregulation in Barrett’s esophagus precedes the development of esophageal adenocarcinoma , 2001 .
[56] S. Hamilton,et al. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. , 1998, The American journal of pathology.